Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hiroko, Yuzawa"'
Autor:
Hiroko Yuzawa, Yousuke Hirose, Tomonori Kimura, Keisuke Shinozaki, Moe Oguchi, Tomohiro Morito, Tomohito Sadahiro
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Background In continuous renal replacement therapy (CRRT), administration of anticoagulants is necessary for achieving a certain level of filter lifetime. Generally, anticoagulant doses are controlled to keep activated partial thromboplastin
Externí odkaz:
https://doaj.org/article/a8d37a1917e7429ab05995d015f493d2
Publikováno v:
Journal of the Japanese Society of Intensive Care Medicine. 28:537-541
Autor:
Taira Nakayama, Haruchika Masuda, Shunya Takizawa, Takatoshi Sorimachi, Eiichiro Nagata, Ryoko Imazeki, Takayuki Asahara, Shizuka Netsu, Hiroko Yuzawa, Mitsunori Matsumae, Natsuko Fujii, Saori Kohara, Takahiro Osada
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Scientific Reports
Scientific Reports
Moyamoya disease (MMD) is well known to be caused by insufficient cerebral vascular formation. However, the essential pathogenesis has not yet been identified. Using our recently developed technique of generating vasculogenic and anti-inflammatory cu
Autor:
Tomohiro Morito, Moe Oguchi, Keisuke Shinozaki, Hiroko Yuzawa, Yousuke Hirose, Tomohito Sadahiro, Tomonori Kimura
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-8 (2021)
Background In continuous renal replacement therapy (CRRT), administration of anticoagulants is necessary for achieving a certain level of filter lifetime. Generally, anticoagulant doses are controlled to keep activated partial thromboplastin time and
Autor:
Hiroko Yuzawa, Shohei Mizushima, Tomohiro Morito, Yousuke Hirose, Moe Oguchi, Tomohito Sadahiro, Tomonori Kimura
Publikováno v:
Acute Medicine & Surgery
Direct hemoperfusion was useful for the treatment of phenobarbital poisoning. It decreased the blood levels of phenobarbital and improved the level of consciousness.
Aim Phenobarbital overdose can cause coma and even death. The consciousness dis
Aim Phenobarbital overdose can cause coma and even death. The consciousness dis
Autor:
Taira Nakayama, Ryoko Imazeki, Natsuko Fujii, Saori Kohara, Hiroko Yuzawa, Takayuki Asahara, Takahiro Osada, Shunya Takizawa, Mitsunori Matsumae, Eiichiro Nagata, Takatoshi Sorimachi, Haruchika Masuda, Shizuka Netsu
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Autor:
Asako Yanagisawa, Hiroko Yuzawa, Yousuke Hirose, Takashi Ohashi, Hisanori Sugawara, Sho Kimura, Sono Toi, Tomonori Kimura, Tomohito Sadahiro
Publikováno v:
Acute Medicine & Surgery
Case A 42-year-old Peruvian woman residing in Japan for 11 years with a family history of neurocysticercosis presented to our intensive care unit with fever and intense headache. Computed tomography indicated multiple micronodular lesions in the brai
Autor:
Takatoshi Kakuta, Susumu Takekoshi, Yoshitaka Mori, Masafumi Fukagawa, Hiroko Yuzawa, Takayo Miyakogawa, Atsushi Kawakami, Toshio Miyata, Hiroyuki Kobayashi
Publikováno v:
Therapeutic Apheresis and Dialysis. 20:645-654
Pyridoxamine, a reactive carbonyl (RCO) scavenger, can ameliorate peritoneal deterioration in uremic peritoneal dialysis (PD) rats when given via dialysate. We examined the effects of scavenging circulating RCOs by oral pyridoxamine. Rats underwent n
Autor:
Tomohito, Sadahiro, Hiroko, Yuzawa, Tomonori, Kimura, Moe, Oguchi, Tomohiro, Morito, Shohei, Mizushima, Yousuke, Hirose
Publikováno v:
Contributions to nephrology. 196
Continuous venovenous hemodiafiltration is the modality of choice for acute blood purification therapy at almost all medical institutions in Japan. Nafamostat mesilate, an ultrashort-acting anticoagulant, is widely used for anticoagulation. Due to re
Autor:
Moe Oguchi, Yousuke Hirose, Tomohito Sadahiro, Tomonori Kimura, Tomohiro Morito, Shohei Mizushima, Hiroko Yuzawa
Continuous venovenous hemodiafiltration is the modality of choice for acute blood purification therapy at almost all medical institutions in Japan. Nafamostat mesilate, an ultrashort-acting anticoagulant, is widely used for anticoagulation. Due to re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c88e7b3d08a4c6eb80d0f660a2580c6d
https://doi.org/10.1159/000485724
https://doi.org/10.1159/000485724